The historical rank and industry rank for CellSource Co's Gross Margin % or its related term are showing as below:
TSE:4880'
s Gross Margin % Range Over the Past 10 Years
Min: 57.78 Med: 70.97 Max: 72.23
Current: 68.53
During the past 7 years, the highestGross Margin % of CellSource Co was 72.23%. The lowest was 57.78%. And the median was 70.97%.
TSE:4880's Gross Margin % is ranked better than 58.29% of 748
companies
in the Biotechnology industry
Industry Median: 59.99
vs TSE:4880: 68.53
CellSource Co had a gross margin of 65.09% for the quarter that ended in Jan. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for CellSource Co was -0.20% per year.
CellSource Co Gross Margin % Historical Data
The historical data trend for CellSource Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CellSource Co's Gross Margin %
For the Biotechnology subindustry, CellSource Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellSource Co's Gross Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CellSource Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where CellSource Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
CellSource Co (TSE:4880) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
CellSource Co had a gross margin of 65.09% for the quarter that ended in Jan. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
CellSource Co Gross Margin % Related Terms
Thank you for viewing the detailed overview of CellSource Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4880 has been successfully added to your 